SPL 2.11% 9.3¢ starpharma holdings limited

Ann: US patent issued for DEP cabazitaxel nanoparticle, page-27

  1. 1,385 Posts.
    lightbulb Created with Sketch. 140
    Let’s hope so. Personally, someone who has recently lost a parent to that horrendous condition they call cancer, I, for one am hoping one of the big boys buys us out. I’m sure they could get our DEP portfolio to market as quickly as they want and start actually giving some people extra time and quality of life. $2 fine, I don’t care. If our tech is that good, then please stop stuffing around and get it done. The problem is, at the end of the day, it’s all about the $$. We all only have one life
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.